TXMD
TXMD
NASDAQ · Pharmaceuticals

Therapeuticsmd Inc

$2.34
+0.05 (+2.18%)
As of Mar 25, 5:15 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +407.7% upside
Low Target $7.57
Average Target $11.88
High Target $17.16
Current Price $2.34
Current
$2.34
Target
$11.88
$7.57 $11.88 avg $17.16
Scenario Analysis
Bear Case
$7.57
223.5%
Low target
Base Case
$11.88
+407.7%
Avg target
Bull Case
$17.16
+633.3%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$2.95
-20.7% from high
52-Week Low
$0.74
+214.3% from low
Target vs 52W High
$11.88
+302.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%